KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Health Investors (NHI) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for National Health Investors (NHI) over the last 17 years, with Q3 2025 value amounting to $62.5 million.

  • National Health Investors' Free Cash Flow rose 2858.99% to $62.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$32.8 million, marking a year-over-year decrease of 11697.19%. This contributed to the annual value of $69.6 million for FY2024, which is 5242.16% down from last year.
  • According to the latest figures from Q3 2025, National Health Investors' Free Cash Flow is $62.5 million, which was up 2858.99% from $3.3 million recorded in Q2 2025.
  • Over the past 5 years, National Health Investors' Free Cash Flow peaked at $62.5 million during Q3 2025, and registered a low of -$70.7 million during Q4 2024.
  • Over the past 5 years, National Health Investors' median Free Cash Flow value was $48.6 million (recorded in 2024), while the average stood at $31.4 million.
  • As far as peak fluctuations go, National Health Investors' Free Cash Flow soared by 98311.42% in 2022, and later plummeted by 23286.66% in 2024.
  • Quarter analysis of 5 years shows National Health Investors' Free Cash Flow stood at $53.4 million in 2021, then dropped by 15.91% to $44.9 million in 2022, then increased by 18.57% to $53.2 million in 2023, then tumbled by 232.87% to -$70.7 million in 2024, then surged by 188.46% to $62.5 million in 2025.
  • Its Free Cash Flow stands at $62.5 million for Q3 2025, versus $3.3 million for Q2 2025 and -$28.0 million for Q1 2025.